Home › Funds › Soleus Capital Management, L.P. › LEGN

Soleus Capital Management, L.P. position in LEGN

LEGEND BIOTECH CORP · Health Care

Soleus Capital Management, L.P. reported holding 1,085,550 shares of LEGN (LEGEND BIOTECH CORP) in its Q3 2026 13F filing — a position valued at US$21.6M, representing 0.77% of its reported portfolio and ranking #29 among its reported holdings. Soleus Capital Management, L.P. has disclosed LEGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.09M sh
Reported value held$21.59M
Portfolio Weight0.77%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s LEGN position evolved

Soleus Capital Management, L.P. first disclosed a stake in LEGN in Q2 2026 at 1,205,000 shares (US$34.8M). Across 2 filings, Soleus Capital Management, L.P. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,085,550 shares valued at US$21.6M — a reduction of -119,450 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.21M $34.80M New
Q3 2026 1.09M $21.59M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LEGN and 13F data

LEGN (LEGEND BIOTECH CORP) is a Health Care company. 12 other funds we track also report a position in LEGN — the largest reported positions include Kynam Capital Management, LP (US$182.1M), Hillhouse Capital (HHLR Advisors) (US$166.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$161.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LEGN

All LEGN fund holders →

FAQ

How long has Soleus Capital Management, L.P. held LEGN?

Soleus Capital Management, L.P. has disclosed LEGN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Soleus Capital Management, L.P.'s current position in LEGN?

As of Q3 2026, Soleus Capital Management, L.P. holds 1.09M shares of LEGN (LEGEND BIOTECH CORP), valued at $21.59M, representing 0.77% of its reported portfolio and ranking #29.

Has Soleus Capital Management, L.P. been buying or selling LEGN?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. reduced its position in LEGN.

Which other funds hold LEGN?

Other major institutional holders of LEGN include Kynam Capital Management, LP, Hillhouse Capital (HHLR Advisors), DEERFIELD MANAGEMENT COMPANY, L.P., among 12 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.